Docsity
Docsity
Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity

Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan

Guidelines and tips
Guidelines and tips
Sell on Docsity
Sell on Docsity
Docsity AI
Docsity AI
Log inSign up

Prepare for your exams

Study with the several resources on Docsity

Find documents

Prepare for your exams with the study notes shared by other students like you on Docsity

Search for your university

Find the specific documents for your university's exams

Docsity AINEW

Summarize your documents, ask them questions, convert them into quizzes and concept maps

Explore questions

Clear up your doubts by reading the answers to questions asked by your fellow students

Earn points to download

Earn points by helping other students or get them with a premium plan

Share documents
download point icon20 Points

For each uploaded document

Answer questions
download point icon5 Points

For each given answer (max 1 per day)

All the ways to get free points
Get points immediately

Choose a premium plan with all the points you need

Study Opportunities

Choose your next study program

Get in touch with the best universities in the world. Search through thousands of universities and official partners

Community

Ask the community

Ask the community for help and clear up your study doubts

Free resources

Our save-the-student-ebooks!

Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors

Abbott India Analysis, Thesis of Business Systems

Amity Business SchoolBusiness Systems

It gives a brief analysis about the Pharmaceutical industry.

Typology: Thesis

2022/2023

Uploaded on 02/14/2023

hiba-fatima-2
hiba-fatima-2 🇮🇳

1 document

1 / 4

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Abbott India Limited
General Overview:
Since 1910, Abbott has been dedicated to helping people in India live
healthier lives through a diverse range of science-based nutritional
products, diagnostic tools, branded generic pharmaceuticals, and
diabetes and vascular devices.
Headquartered in Mumbai, Abbott India Limited, a publicly listed
company and a subsidiary of Abbott Laboratories, takes pride in
offering high-quality trusted medicines in multiple therapeutic
categories such as women's health, gastroenterology, cardiology,
metabolic disorders and primary care.
One of India's fastest-growing pharmaceutical companies, Abbott India
Limited is part of Abbott's global pharmaceutical business in India.
Shareholding Pattern :
Holder's Name No of Shares % Share Holding
NoOfShares 21249302 100%
Promoters 0 0%
ForeignInstitutions 43299 0.2%
NBanksMutualFunds 1028506 4.84%
Others 455702 2.14%
GeneralPublic 3127610 14.72%
FinancialInstitutions 660137 3.11%
ForeignPromoter 15934048 74.99%
Management: Vivek V Kamath – Managing Director
Mr. Vivek V Kamath has over 30 years of rich and diversified
experience in healthcare, including pharmaceuticals, OTC and
diagnostics. He has held several senior leadership positions in various
reputed pharmaceutical companies, Indian as well as MNCs, across
pf3
pf4

Partial preview of the text

Download Abbott India Analysis and more Thesis Business Systems in PDF only on Docsity!

Abbott India Limited

General Overview: Since 1910, Abbott has been dedicated to helping people in India live healthier lives through a diverse range of science-based nutritional products, diagnostic tools, branded generic pharmaceuticals, and diabetes and vascular devices. Headquartered in Mumbai, Abbott India Limited, a publicly listed company and a subsidiary of Abbott Laboratories, takes pride in offering high-quality trusted medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. One of India's fastest-growing pharmaceutical companies, Abbott India Limited is part of Abbott's global pharmaceutical business in India.

Shareholding Pattern :

Holder's Name No of Shares % Share Holding NoOfShares 21249302 100% Promoters 0 0% ForeignInstitutions 43299 0.2% NBanksMutualFunds 1028506 4.84% Others 455702 2.14% GeneralPublic 3127610 14.72% FinancialInstitutions 660137 3.11% ForeignPromoter 15934048 74.99%

Management: Vivek V Kamath – Managing Director

Mr. Vivek V Kamath has over 30 years of rich and diversified experience in healthcare, including pharmaceuticals, OTC and diagnostics. He has held several senior leadership positions in various reputed pharmaceutical companies, Indian as well as MNCs, across

different geographies and holds strong functional expertise in the areas of strategy, marketing, sales & general management. Rajiv Sonalker – CFO and Whole-time Director. Rajiv joined as Director - Finance in November 2006 and has 29 years of experience in the Pharmaceutical, FMCG and Engineering sectors. Prior to joining Abbott India, he worked with Bristol-Myers Squibb as Director – Finance. Rajiv has also worked with Voltas Ltd, Johnson & Johnson, Sanofi - Aventis in India and Germany.

Strengths:  Company with high TTM EPS Growth 413.9% returns for Nifty 500 over 5.4 years  Increasing Revenue every Quarter for the past 8 Quarters 77.1% returns for Nifty 500 over 4.5 years  Effectively using its capital to generate profit - RoCE improving in last 2 years -16.8% returns for Nifty 500 over 1.9 years  Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year  Efficient in managing Assets to generate Profits - ROA improving since last 2 year  Growth in Net Profit with increasing Profit Margin (QoQ)  Growth in Quarterly Net Profit with increasing Profit Margin (YoY)  Company with No Debt  Increasing Revenue every Quarter for the past 4 Quarters  Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years  Annual Net Profits improving for last 2 years  Book Value per share Improving for last 2 years  Company with Zero Promoter Pledge  Near 52 Week High

Conclusion:

Hence it is a good company for investment.